- Home
- RIO vs BMY Comparison
RIO vs BMY Comparison
Compare RIO & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIO
- BMY
- Stock Information
- Founded
- RIO 1873
- BMY 1887
- Country
- RIO United Kingdom
- BMY United States
- Employees
- RIO N/A
- BMY N/A
- Industry
- RIO Metal Mining
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- RIO Basic Materials
- BMY Health Care
- Exchange
- RIO Nasdaq
- BMY Nasdaq
- Market Cap
- RIO 110.7B
- BMY 94.0B
- IPO Year
- RIO N/A
- BMY N/A
- Fundamental
- Price
- RIO $70.67
- BMY $43.71
- Analyst Decision
- RIO Hold
- BMY Hold
- Analyst Count
- RIO 1
- BMY 14
- Target Price
- RIO N/A
- BMY $57.54
- AVG Volume (30 Days)
- RIO 3.4M
- BMY 17.4M
- Earning Date
- RIO 07-30-2025
- BMY 10-30-2025
- Dividend Yield
- RIO 5.25%
- BMY 5.66%
- EPS Growth
- RIO N/A
- BMY N/A
- EPS
- RIO 6.28
- BMY 2.49
- Revenue
- RIO $53,729,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- RIO $5.07
- BMY N/A
- Revenue Next Year
- RIO $1.45
- BMY N/A
- P/E Ratio
- RIO $11.24
- BMY $17.63
- Revenue Growth
- RIO N/A
- BMY 2.57
- 52 Week Low
- RIO $51.67
- BMY $42.96
- 52 Week High
- RIO $71.24
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- RIO 68.14
- BMY 42.20
- Support Level
- RIO $68.11
- BMY $43.52
- Resistance Level
- RIO $71.24
- BMY $45.23
- Average True Range (ATR)
- RIO 1.21
- BMY 0.73
- MACD
- RIO 0.18
- BMY 0.06
- Stochastic Oscillator
- RIO 90.25
- BMY 28.30
About RIO Rio Tinto Plc
Rio Tinto is a global diversified miner. Iron ore is the dominant commodity, with significantly lesser contributions from copper, aluminum, diamonds, gold, and industrial minerals. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.